Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ricerca Granted DEA License | Contract Pharma

What are you searching for?

Sign in
Breaking News

Ricerca Granted DEA License

Ricerca Biosciences has been granted a Drug Enforcement Administration (DEA) license.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ricerca Biosciences has been granted a Drug Enforcement Administration (DEA) license. The DEA license allows the company to handle multiple kilos of controlled Schedule II-V substances for R&D projects at its Concord, OH facility, including preparation of Phase I to Phase II clinical bulk API supplies.

DEA licenses companies based on documented accountability of material usage and disposal, secure storage and strong ICH Q7A compliance, as well as a team of experienced chemists to execute the complex synthetic routes.

“We have the ability to move forward on clients’ R&D projects that require a DEA license with no delay,” said Rich Donaldson, Ph.D., vice president of chemical development at Ricerca. “We are proud of our track record and dedication to excellence supporting this license, and more importantly, the license signifies our commitment to rapidly moving projects forward.”


Click here to learn more about Ricerca

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters